UX007
UX007G-CL301
Phase 3 small_molecule terminated
Quick answer
UX007 for Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) is a Phase 3 program (small_molecule) at Ultragenyx Pharmaceutical with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated